Biotech Values

[genisi]

Unfortunately, the Supreme Court’s opinion does not clarify what is patentable subject matter under 35 USC § 101. It appears likely that some business method patent claims (such as Myriad's) and a majority of software method patent claims are now patentable subject matter under section 101, but determining which ones are patentable will be difficult. I expect that further court opinions at the level of district courts and the Court of Appeals for the Federal Circuit will attempt to make some sense of this.